glp-1 and eye disease The Link between Drugs Diabetic Retinopathy Is Not So Clear | AAO 2024 GLP-1s and Rapid Facial Aging:

While this initial adjustment can help with portion control, visible weight loss typically becomes more noticeable after 2-4 weeks of consistent use, as the medication continues to regulate appetite and promote more sustainable eating habits

Chan S, Cao C, Pascoe EM, et al

This means that the effects will happen more gradually, with symptoms often taking some time to improve

Untangling immune cell contributions in the progression from GERD to Barretts esophagus and esophageal cancer: insights from genetic causal analysis

Here, though, we again run into the issue of your body not being able to absorb the majority of external glutathione just like with supplements

Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms